The incidence of decreased leucopenia, neutropenia, and diarrhea was 13.16%, 10.53%, and 15.79%, respectively, and above AEs were of grade 1/2, which were substantially lower than those previously reported in CDK4/6i plus endocrine therapy3. The gene discussed is CDK4; the disease is neutropenia.